You are here: Home » PTI Stories » National » News
Business Standard

SRMCRI, MedGenome set up genomics centre

Health Medical Pharma

Press Trust of India  |  Chennai 

The Sri Ramachandra Medical College and Research Institute (SRMCRI) and MedGenome, global leader in research and diagnostics, today announced the launch of a new genomics centre here.

The centre located at the SRMCRI in Porur, would provide an environment for doctors and researchers to translate "Next Generation Sequencing" based genomic solutions into new and actionable patient services, a press release said.

"The focus of the facility will be to deliver the most up-to-date genomic-based diagnostics for patients and also provide researchers a great opportunity to advance their understanding of the human biology," it said.

The release said that a Genetic Health Clinic will also be set up to offer counselling to patients on hereditary cancers, pregnancy-related issues, genetic and neurological disorders.

"We are extremely pleased to be collaborating with MedGenome. This is an exciting step forward in our efforts to deliver the benefits of the latest technologies and research in genomics..." said SRMCRI, Dean of Research, S P Thyagarajan.

The advanced genomic-based diagnostic solutions by MedGenome would enable the clinicians to identify the precise genetic causes for a disease and offer the best and most suitable treatments, he said.

MedGenome currently offers more than 550 genetic tests across key disease areas at its lab in Bengaluru.

"We are grateful to SRMCRI for recognising the excellence of MedGenome's genomic capabilities in research and diagnostics", MedGenome, COO, V L Ramprasad said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, January 31 2018. 23:25 IST